About: Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Cassava Sciences, Inc. and changed its name to Filana Therapeutics, Inc. in March 2026. The company was incorporated in 1998 and is based in Austin, Texas.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.21 (-6.23%)
Status: deslistada — removed_from_provider. Este ativo não é mais negociado; são exibidos dados históricos.
SAVA NASDAQ Cassava Sciences Inc
Cassava Sciences Inc share price
Atividade de preço de SAVA
Último preço
Variação (24h)
USD
Volume
-
Volume (média 4 sem.)
-
Fechamento anterior
N/D
Último negócio
SAVA price performance
quote.marketSignals